Correlation Between PET/CT Findings of Distant Metastases and the Findings of Biopsy and Other Imaging Modalities in 20 Patients with IBC
| PET/CT findings | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chest | Abdomen | Contralateral LNs | ||||||||||
| Patient no. | Musculoskeletal | Pulmonary | Pleural | Mediastinal | Liver | LNs | Axillary | Subpectoral | Internal mammary | Supraclavicular | Biopsy | Correlative imaging |
| 1* | + | + | Pos (supraclavicular) | CT, FU | ||||||||
| 2† | + | 0 | MRI | |||||||||
| 3 | + | + | 0 | CT, WBS | ||||||||
| 4 | + | + | + | + | 0 | FU | ||||||
| 5† | + | Pos (supraclavicular) | US, FU | |||||||||
| 6 | + | + | Pos (axillary) | CT, FU | ||||||||
| 7 | − (FN) | Pos (axillary) | US, CT | |||||||||
| 8 | + | 0 | CT | |||||||||
| 9* | + | Pos (chest wall) | US, CT | |||||||||
| 10* | + | + | + | + | 0 | CT, WBS, FU | ||||||
| 11† | + | 0 | CT | |||||||||
| 12 | + | − (FN) | + | + | 0 | CT, WBS, FU | ||||||
| 13 | − (FN) | + | + | + | Pos (pleural) | CT | ||||||
| 14* | + | + | + | + | + | 0 | CT, WBS | |||||
| 15† | + | 0 | MRI | |||||||||
| 16† | + | + | + | + (FP) | Neg (axillary) | CT, MRI | ||||||
| 17 | + | − (FN) | + | + | + | 0 | CT, WBS, FU | |||||
| 18 | + | + | Pos (axillary) | CT, US | ||||||||
| 19† | + | 0 | CT | |||||||||
| 20† | + | 0 | FU | |||||||||
↵* Patients who presented with clinical features suggestive of metastases.
↵† Patients who did not have clinical suspicion or imaging evidence of metastases before PET/CT.
LNs = lymph nodes; + = positive on PET/CT; Pos = positive; FU = follow up with PET/CT; US = ultrasound; − = negative on PET/CT; FN = false-negative; FP = false-positive; Neg = negative.